Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative.

ABSTRACT:

Background

Trials have shown that for patients on oral anticoagulants (OAC), a short course of dual antiplatelet therapy (DAPT) with OAC reduces post-percutaneous coronary intervention (PCI) bleeding without increasing ischemic events. Adoption of this strategy has been variable. We evaluated the impact of an institutional quality improvement (QI) initiative to reduce the use of triple therapy (TT, OAC + DAPT) and improve discharge communication post-PCI.

Methods

A hospital-wide QI initiative was developed to minimize time on TT post-PCI. Interventions included institutional guidelines emphasizing discharge on OAC with a P2Y12 inhibitor or reducing TT duration to ≤30 days, changes to the computerized decision-support system, and an educational curriculum for house staff. PCI

SUBMITTER: Earle W 

PROVIDER: S-EPMC9712225 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature